Baseline characteristics for INFRONT 3: A Phase 3 double blind, placebo[...]
Notification Letter and Reply Form to Non registered Shareholders[...]
11/29/2021 | Press release | Distributed by Public on 11/29/2021 16:15
Please select the service you want to use:
Smartlinks | Investigator Resources Limited | Finance | Metals Markets | Stock Markets | Security Markets | Commodities | Stock Markets | Security Markets | Company News | Metals | Precious Metals and Minerals | Non-Ferrous Metals | Metals Markets | Public Companies | Mining and Exploration Companies | Börse Frankfurt | Australian Securities Exchange (ASX) | Börse Berlin | Tradegate Exchange | Chi-X Australia
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact